Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eureka Prima Jakarta Tbk. (LCGP) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Eureka Prima Jakarta Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Eureka Prima Jakarta Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Eureka Prima Jakarta Tbk. trades at Rp114 (market cap 641.82B), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Eureka Prima Jakarta Tbk. is far larger — about 3.9× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.

LCGPOBAT
Market Cap
641.82B166.01B
Volume
324K
Lot
3.24K
Turnover
77.68M
Average Price
239.75
Value
77.68M
Indicative Equilibrium Price
240
Indicative Equilibrium Volume
1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

OBAT
View details

About Eureka Prima Jakarta Tbk.

PT Eureka Prima Jakarta Tbk formerly Laguna Cipta Griya Tbk (the company) was established based on notarial deed No. 97 dated May 17, 20014 of Bambang Suwondo, S.H., notary in Jakarta and has been amended based on the deed No. 4 dated June 4, 2004 before notary H. Yunardi, S.H. The Company’s articles of association has been amended several times, most recently by notarial deed No. 40 of Fathiah Helmi, S.H., dated Jan 30, 2007, concerning among others, change the company's name.

Read more on LCGP

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT